<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="26890">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02092415</url>
  </required_header>
  <id_info>
    <org_study_id>Junctional Tourniquet</org_study_id>
    <nct_id>NCT02092415</nct_id>
  </id_info>
  <brief_title>Assessment of Limb Perfusion During Junctional Tourniquet</brief_title>
  <official_title>Assessment of Limb Perfusion During Junctional Tourniquet</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oregon Health and Science University</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to use contrast enhanced ultrasound to determine the degree to
      which flow is reduced during application of a junctional tourniquet (JT).  Contrast enhanced
      ultrasound is performed to quantify thigh and calf perfusion at baseline and during
      application of the JT
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">February 2015</completion_date>
  <primary_completion_date type="Anticipated">February 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Muscle Perfusion</measure>
    <time_frame>One minute (post junctional tourniquet application)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Contrast ultrasound perfusion imaging will be performed at baseline and 1 min after application of the JT.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Bleeding</condition>
  <arm_group>
    <arm_group_label>Normal subjects</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Normal subjects, all of whom undergo brief application of junctional tourniquet</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Application of a Junctional Tourniquet</intervention_name>
    <description>All subjects will be studied at baseline and after placement of a junctional tourniquet to the femoral artery.</description>
    <arm_group_label>Normal subjects</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy subject

          -  Age 19-50

        Exclusion Criteria:

          -  Peripheral artery disease

          -  Known heart failure

          -  Right to left shunt

          -  Pregnancy

          -  Presence of femoral artery aneurysm
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jonathan R Lindner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oregon Health and Science University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jonathan R Lindner, MD</last_name>
    <phone>503 494-8750</phone>
    <email>lindnerj@ohsu.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>OHSU</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonathan R Lindner, MD</last_name>
      <phone>503-494-8750</phone>
      <email>lindnerj@ohsu.edu</email>
    </contact>
    <investigator>
      <last_name>Jonathan R Lindner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Brian Davidson, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 18, 2014</lastchanged_date>
  <firstreceived_date>January 6, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oregon Health and Science University</investigator_affiliation>
    <investigator_full_name>Jonathan R. Lindner, MD</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Tourniquet</keyword>
  <keyword>Muscle perfusion</keyword>
  <keyword>Contrast ultrasound</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
